RH Bophelo was initially incorporated as a private company in 2017. It was later converted into a public company and its name was changed to RH Bophelo – as it now stands.
RH Bophelo (RHB) is a healthcare investment vehicle that aims to produce superior returns, whilst contributing to socio-economic value creation and development of South Africa and making an important contribution to ongoing transformation in South Africa.
The intended purpose of the company, following the JSE listing, will be to pursue acquisitions of healthcare assets in exceptionally managed commercial entities or special situations across the South African market. However, a tenth of the fund will be allocated for social assets.
We collaborate and work with individuals who are uniquely qualified to deliver exceptional performance for shareholders and possess direct equity, debt investment, portfolio management, business, political and legal experience across varied asset classes and sectors (in particular healthcare) in the South African market, on the African continent and internationally.
The company has been structured to deliver shareholders a growth oriented cash generative return, without the negative structural elements of traditional junior debt and private equity funds, namely management fees, illiquidity and opaque governance.